VitaPath gets $6M to fight spina bifida
VitaPath Genetics, developer of a diagnostic that could be used to lessen rates of the birth defect spina bifida, has raised $6 million in a first round of funding led by Mohr Davidow Ventures. The money should provide the Foster City, Calif. with runway through next year, covering testing for women with a high chance of having a baby with spina bifida.
The condition, which causes a underdeveloped spinal column often leading to nerve and brain… Continue Reading
OPX lands $17.5M for cheaper, faster biofuel production
OPX Biotechnologies, a biotech firm that focuses on engineering microorganisms to better break down organic products into cost-effective fuel sources, just closed its second round of funding at $17.5 million. The money will go toward construction of a demonstration plant slated to open in 2011 — laying the groundwork for broader commercialization a little over a year later.
This isn’t your standard ethanol or biodeisel production. OPX is altering the DNA of bacteria and fungi that… Continue Reading
Allopartis nabs $750K seed round for biomass fuels
Cleantech firm Allopartis Biotechnologies raised $750,000 in seed funding from CalCEF Angel Fund and X/Seed Capital Management, reports peHUB.
The San Francisco-based company is working on technology that can convert sustainable biomass products into clean-burning fuel sources.